# IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer

> **NCT00100893** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 37 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** IH636 grape seed proanthocyanidin extract

## Key facts

- **NCT ID:** NCT00100893
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100893, "IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00100893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*